CircZNF236 modulates OSCC via the miR-145-5p/MBTD1 axis. These results support the potential of circZNF236 as a treatment target for OSCC.
CircZNF236 facilitates malignant progression in oral squamous cell carcinoma by sequestering miR-145-5p.